Drug treatments for obesity: orlistat, sibutramine...[Lancet. 2007] - PubMed Result

Responses:

This Wall Street Journals Blog http://blogs.wsj.com/health/2007/06/29/sanofi-retreats-on-acomplia-vows-to-try-again/ reports (June 29th 2007):

"Rather than wait for an FDA rejection that had come to seem inevitable, Sanofi-Aventis today withdrew its application to sell its weight-loss drug Zimulti in the United States.

The drug, known generically as rimonabant and sold as Acomplia in Europe, was trounced a few weeks ago by an FDA advisory panel concerned by the drug’s psychiatric side effects."

Conflict of Interests - None